{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:55:06Z","timestamp":1788288906164,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jpet.2025.103606","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:52:52Z","timestamp":1747219972000},"page":"103606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer\u2019s drug discovery: Promising futuristic structural designs"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2832-8203","authenticated-orcid":false,"given":"Atukuri","family":"Dorababu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103606_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020\u20132023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jpet.2025.103606_bib2","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.jpet.2025.103606_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1039\/D4MD00630E","article-title":"Recent advancements in the therapeutic approaches for Alzheimer\u2019s disease treatment: current and future perspective","volume":"16","author":"Sharma","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jpet.2025.103606_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jpet.2025.103606_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jpet.2025.103606_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2025.103606_bib8","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.3390\/biomedicines12122816","article-title":"Recent advances in Alzheimer\u2019s disease research: from biomarkers to therapeutic frontiers","volume":"12","author":"L\u00f3pez-Ant\u00f3n","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpet.2025.103606_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/ijms13010427","article-title":"Adaptation of high-throughput screening in drug discovery\u2014toxicological screening tests","volume":"13","author":"Szyma\u0144ski","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103606_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-020-00662-x","article-title":"Repurposed agents in the Alzheimer\u2019s disease drug development pipeline","volume":"12","author":"Bauzon","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jpet.2025.103606_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fneur.2020.00223","article-title":"Diagnostic accuracy of the ambulatory EEG vs. routine EEG for first single unprovoked seizures and seizure recurrence: the DX-seizure study","volume":"11","author":"Hern\u00e1ndez-Ronquillo","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jpet.2025.103606_bib12","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.3233\/JAD-230783","article-title":"Advances and challenges in gene therapy for Alzheimer\u2019s disease","volume":"101","author":"Morroni","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jpet.2025.103606_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307567","article-title":"Clinician\u2019s perspectives on gene therapy for Alzheimer\u2019s disease: a qualitative study","volume":"19","author":"Kelemen","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103606_bib14","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11064-024-04178-w","article-title":"Biomarkers and target-specific small-molecule drugs in Alzheimer\u2019s diagnostic and therapeutic research: from amyloidosis to tauopathy","volume":"49","author":"Sheng","year":"2024","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jpet.2025.103606_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1019412","article-title":"Small-molecule drugs development for Alzheimer\u2019s disease","volume":"14","author":"Yao","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jpet.2025.103606_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14638","article-title":"Recent advances in medicinal chemistry of memantine against Alzheimer\u2019s disease","volume":"104","author":"Singh","year":"2024","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.jpet.2025.103606_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/acscombsci.8b00088","article-title":"Combating a master manipulator: Staphylococcus aureus immunomodulatory molecules as targets for combinatorial drug discovery","volume":"20","author":"Rakesh","year":"2018","journal-title":"ACS Comb Sci"},{"key":"10.1016\/j.jpet.2025.103606_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2020.100067","article-title":"Multi-targeted quinazolinone-Schiff\u2019s bases as potent bio-therapeutics","volume":"2","author":"Ullas","year":"2020","journal-title":"Results Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5155\/eurjchem.6.3.254-260.1233","article-title":"Quinazolinones linked amino acids derivatives as a new class of promising antimicrobial, antioxidant and anti-inflammatory agents","volume":"6","author":"Rakesh","year":"2015","journal-title":"Eur J Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib20","doi-asserted-by":"crossref","first-page":"33540","DOI":"10.1039\/D1RA05972F","article-title":"Synthesis of indole derivatives as prevalent moieties present in selected alkaloids","volume":"11","author":"Heravi","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.jpet.2025.103606_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10870-018-0706-6","article-title":"Structural investigation, UV\u2013vis analysis and crystal packing of spiro[chromeno[4,3-b]quinoline-6,1\u2032-cycloalkan]-7-amine: novel tacrine hybrids by single crystal X-ray diffraction","volume":"48","author":"Bonacorso","year":"2018","journal-title":"J Chem Crystallogr"},{"key":"10.1016\/j.jpet.2025.103606_bib22","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1016\/j.tetlet.2015.11.008","article-title":"Synthesis, biological evaluation and molecular docking study of 7-amine-spiro[chromeno[4,3-b]quinoline-6,1\u2032-cycloalkanes] as new tacrine hybrids","volume":"56","author":"Bonacorso","year":"2015","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.jpet.2025.103606_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106704","article-title":"1,2,3-Triazolo[4,5-b]aminoquinolines: design, synthesis, structure, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, and molecular docking of novel modified tacrines","volume":"139","author":"Kappenberg","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib24","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.3390\/molecules25173915","article-title":"New hybrids of 4-amino-2,3-polymethylene-quinoline and p-tolylsulfonamide as dual inhibitors of acetyl- and butyrylcholinesterase and potential multifunctional agents for Alzheimer\u2019s disease treatment","volume":"25","author":"Makhaeva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","article-title":"Tackling neuroinflammation and cholinergic deficit in Alzheimer\u2019s disease: multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase","volume":"167","author":"AlFadly","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2174\/1570159X16666180412091908","article-title":"Therapeutic potential of multifunctional tacrine analogues","volume":"17","author":"Przyby\u0142owska","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jpet.2025.103606_bib27","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","article-title":"Sulfonamide derivatives as multi-target agents for complex diseases","volume":"29","author":"Apayd\u0131n","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpet.2025.103606_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110620","article-title":"Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer\u2019s disease","volume":"382","author":"Mato\u0161evi\u0107","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jpet.2025.103606_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2019.05.024","article-title":"Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase","volume":"308","author":"Bosak","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jpet.2025.103606_bib30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/pharmaceutics14061305","article-title":"4-Aminoquinoline-based adamantanes as potential anticholinesterase agents in symptomatic treatment of Alzheimer\u2019s disease","volume":"14","author":"Komatovi\u0107","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103606_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104649","article-title":"7-Amine-spiro[chromeno[4,3-b]quinoline-6,1\u2032-cycloalkanes]: synthesis and cholinesterase inhibitory activity of structurally modified tacrines","volume":"108","author":"Silva","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.21037\/atm-22-730","article-title":"Design, synthesis, and evaluation of 8-aminoquinoline-melatonin derivatives as effective multifunctional agents for Alzheimer\u2019s disease","volume":"10","author":"Chen","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jpet.2025.103606_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2018.08.005","article-title":"Donepezil-butylated hydroxytoluene (BHT) hybrids as anti-Alzheimer\u2019s disease agents with cholinergic, antioxidant, and neuroprotective properties","volume":"157","author":"Cai","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib34","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.3390\/molecules25245891","article-title":"New multifunctional agents based on conjugates of 4-amino-2,3-polymethylenequinoline and butylated hydroxytoluene for Alzheimer\u2019s disease treatment","volume":"25","author":"Makhaeva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/molecules29010190","article-title":"Novel multi-target agents based on the privileged structure of 4-hydroxy-2-quinolinone","volume":"29","author":"Kostopoulou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib36","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1021\/acs.jmedchem.8b01987","article-title":"New quinolylnitrones for stroke therapy: antioxidant and neuroprotective (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide as a new lead-compound for ischemic stroke treatment","volume":"62","author":"Chioua","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib37","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apsb.2023.01.013","article-title":"8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases","volume":"13","author":"Knez","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jpet.2025.103606_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.918116","article-title":"Synthesis of melatonin derivatives and the neuroprotective effects on Parkinson\u2019s disease models of Caenorhabditis elegans","volume":"10","author":"He","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1374930","article-title":"Discovery of novel melatonin\u2013mydroxyquinoline hybrids as multitarget strategies for Alzheimer\u2019s disease therapy","volume":"12","author":"Wang","year":"2024","journal-title":"Front Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib40","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/molecules25163610","article-title":"Design and synthesis of novel hybrid 8-hydroxy quinoline-indole derivatives as inhibitors of A\u03b2 self-aggregation and metal chelation-induced A\u03b2 aggregation","volume":"25","author":"Bowroju","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11030-024-10927-4","article-title":"Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer\u2019s agents: design, synthesis and biological evaluation","volume":"29","author":"Nagani","year":"2025","journal-title":"Mol Divers"},{"key":"10.1016\/j.jpet.2025.103606_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer\u2019s disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/acschemneuro.3c00588","article-title":"Discovery of quinolinone hybrids as dual inhibitors of acetylcholinesterase and A\u03b2 aggregation for Alzheimer\u2019s disease therapy","volume":"15","author":"Manzoor","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jpet.2025.103606_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22183","article-title":"Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N\u2019-(quinolin-4-ylmethylene)propanehydrazides against Alzheimer\u2019s disease","volume":"85","author":"Kilic","year":"2024","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jpet.2025.103606_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202201223","article-title":"Bivalent metal chelates with pentadentate azo-Schiff base derived from nicotinic hydrazide: preparation, structural elucidation, and pharmacological activity","volume":"20","author":"Abouel-Enein","year":"2023","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jpet.2025.103606_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.03.060","article-title":"Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety","volume":"151","author":"Lv","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113450","article-title":"Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants","volume":"220","author":"Zhu","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib48","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/molecules26030656","article-title":"Microwave-assisted synthesis of (piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as potent inhibitors of cholinesterases: a biochemical and in silico approach","volume":"26","author":"Munir","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib49","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.3390\/molecules28052131","article-title":"Ultrasound-assisted synthesis of piperidinyl-quinoline acylhydrazones as new anti-Alzheimer\u2019s agents: assessment of cholinesterase inhibitory profile, molecular docking analysis, and drug-like properties","volume":"28","author":"Munir","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib50","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1016\/j.bmc.2017.09.033","article-title":"Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies","volume":"25","author":"Elsayed","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bioorg.2018.09.010","article-title":"Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer\u2019s disease: design, synthesis and biological evaluation","volume":"81","author":"He","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14756366.2019.1687460","article-title":"Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer\u2019s disease","volume":"35","author":"Fu","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib53","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/DDDT.S354879","article-title":"Design, synthesis and biological evaluation of new 3,4-dihydro-2(1H)-quinolinone-dithiocarbamate derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Guo","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jpet.2025.103606_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2231661","article-title":"Development of novel salicylic acid\u2013donepezil\u2013rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Zhou","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111572","article-title":"The chemistry toolbox of multitarget-directed ligands for Alzheimer\u2019s disease","volume":"181","author":"Mesiti","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2169682","article-title":"Design, synthesis and evaluation of quinoline-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Chen","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2019.05.056","article-title":"Design, synthesis and biological evaluation of 2-H pyrazole derivatives containing morpholine moieties as highly potent small molecule inhibitors of APC\u2013Asef interaction","volume":"177","author":"Yan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2019.02.015","article-title":"Revealing quinquennial anticancer journey of morpholine: a SAR based review","volume":"167","author":"Arshad","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib59","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3390\/molecules26216573","article-title":"Hybrid quinoline-thiosemicarbazone therapeutics as a new treatment opportunity for Alzheimer\u2019s disease\u2012synthesis, in vitro cholinesterase inhibitory potential and computational modeling analysis","volume":"26","author":"Zaib","year":"2021","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.jpet.2025.103606_bib60","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.2174\/0109298673333159240815061359","article-title":"Exploring novel quinoline-1,3,4-oxadiazole derivatives for Alzheimer\u2019s disease: their design, synthesis, and in-vitro and in-silico investigations","volume":"32","author":"Saffour","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104922","article-title":"Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer\u2019s disease","volume":"111","author":"Choubey","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.101977","article-title":"Design, synthesis and in vitro biological activities of coumarin linked 1,3,4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents","volume":"34","author":"George","year":"2022","journal-title":"J King Saud Univ Sci"},{"key":"10.1016\/j.jpet.2025.103606_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph16010011","article-title":"Synthesis and evaluation of novel S-alkyl phthalimide- and S-benzyl-oxadiazole-quinoline hybrids as inhibitors of monoamine oxidase and acetylcholinesterase","volume":"16","author":"Khan","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2025.103606_bib64","article-title":"SAR studies of quinoline and derivatives as potential treatments for Alzheimer\u2019s disease","volume":"16","author":"Li","year":"2023","journal-title":"Arab J Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib65","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1039\/D3RA05501A","article-title":"Quinoline\u2013sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors","volume":"14","author":"Jalil","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.jpet.2025.103606_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0100-40422002000100022","article-title":"A qu\u00edmica medicinal de N-acilidrazonas: novos compostos-prot\u00f3tipos de f\u00e1rmacos analg\u00e9sicos, antiinflamat\u00f3rios e anti-tromb\u00f3ticos","volume":"25","author":"Barreiro","year":"2002","journal-title":"Quim Nova"},{"key":"10.1016\/j.jpet.2025.103606_bib67","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3390\/ijms20163944","article-title":"Synthesis of new quinoline-piperonal hybrids as potential drugs against Alzheimer\u2019s disease","volume":"20","author":"de Oliveira C Brum","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103606_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2158822","article-title":"New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Czarnecka","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103084","article-title":"Search for multifunctional agents against Alzheimer\u2019s disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivatives","volume":"90","author":"Jo\u0144czyk","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300491","article-title":"Radiosynthesis and whole-body distribution in mice of a 18 F-labeled azepino[4,3-b]indole-1-one derivative with multimodal activity for the treatment of Alzheimer\u2019s disease","volume":"357","author":"Lee","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.jpet.2025.103606_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116353","article-title":"Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults","volume":"270","author":"Samarelli","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/molecules29010068","article-title":"Synthetic approaches to piperazine-containing drugs approved by FDA in the period of 2011\u20132023","volume":"29","author":"Romanelli","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22606\/mocr.2019.41001","article-title":"The stability study of a novel phenylpiperazine derivative","volume":"4","author":"Tarsa","year":"2019","journal-title":"Mod Org Chem Res"},{"key":"10.1016\/j.jpet.2025.103606_bib74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/1570179417666200619132218","article-title":"Indol-2-carboxylic acid esters containing N-phenylpiperazine moiety - preparation and cholinesterase-inhibiting activity","volume":"17","author":"Padrtov\u00e1","year":"2020","journal-title":"Curr Org Synth"},{"key":"10.1016\/j.jpet.2025.103606_bib75","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejmech.2018.07.056","article-title":"Multi-target-directed ligands for Alzheimer\u2019s disease: discovery of chromone-based monoamine oxidase\/cholinesterase inhibitors","volume":"158","author":"Reis","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib76","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/molecules24132392","article-title":"Synthesis and AChE inhibitory activity of novel thiazolylhydrazone derivatives","volume":"24","author":"Osmaniye","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112368","article-title":"Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer\u2019s disease","volume":"198","author":"Rodr\u00edguez-Lavado","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib78","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1080\/14756366.2022.2126464","article-title":"Design and synthesis of new indole drug candidates to treat Alzheimer\u2019s disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy","volume":"37","author":"Lamie","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1062936X.2017.1331467","article-title":"QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors","volume":"28","author":"Bitam","year":"2017","journal-title":"SAR QSAR Environ Res"},{"key":"10.1016\/j.jpet.2025.103606_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116131","article-title":"Design, synthesis, and pharmacological evaluation of indole-piperidine amides as blood\u2212brain barrier permeable dual cholinesterase and \u03b2-secretase inhibitors","volume":"266","author":"Banoo","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib81","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ph16091194","article-title":"Design, synthesis, in silico studies and in vitro evaluation of new indole- and\/or donepezil-like hybrids as multitarget-directed agents for Alzheimer\u2019s disease","volume":"16","author":"Angelova","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2025.103606_bib82","doi-asserted-by":"crossref","first-page":"19609","DOI":"10.1002\/anie.202103878","article-title":"Discovery of neuritogenic Securinega alkaloids from Flueggea suffruticosa by a building blocks-based molecular network strategy","volume":"60","author":"He","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jpet.2025.103606_bib83","doi-asserted-by":"crossref","first-page":"7191","DOI":"10.3390\/molecules26237191","article-title":"Discovery of three new monoterpenoid indole alkaloids from the leaves of Gardneria multiflora and their vasorelaxant and AChE inhibitory activities","volume":"26","author":"Zhang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104638","article-title":"Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of \u03b1-glucosidase enzyme along with in silico study","volume":"108","author":"Alomari","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijbiomac.2020.06.006","article-title":"Inhibition potential of phenyl linked benzimidazole-triazolothiadiazole modular hybrids against \u03b2-glucuronidase and their interactions thereof","volume":"161","author":"Taha","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jpet.2025.103606_bib86","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.3390\/molecules27217368","article-title":"Synthesis, in vitro biological evaluation and in silico molecular docking studies of indole based thiadiazole derivatives as dual inhibitor of acetylcholinesterase and butyrylchloinesterase","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib87","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijbiomac.2021.08.065","article-title":"Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors","volume":"188","author":"Taha","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jpet.2025.103606_bib88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/157340641202160209104115","article-title":"Synthesis of new harmine isoxazoles and evaluation of their potential anti-alzheimer, anti-inflammatory, and anticancer activities","volume":"12","author":"Filali","year":"2016","journal-title":"Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib89","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/molecules25051047","article-title":"Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71729-0","article-title":"Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer\u2019s agents","volume":"14","author":"Iraji","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103606_bib91","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1021\/acs.jmedchem.7b00731","article-title":"Discovery of novel and highly selective inhibitors of calpain for the treatment of Alzheimer\u2019s disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides","volume":"60","author":"Kling","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib92","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1038\/srep09862","article-title":"Curcumin pyrazole and its derivative (N-(3-nitrophenylpyrazole) curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of wild type and mutant \u03b1-synuclein","volume":"5","author":"Ahsan","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103606_bib93","doi-asserted-by":"crossref","first-page":"31539","DOI":"10.1021\/acsomega.1c03978","article-title":"Construction of spirooxindole analogues engrafted with indole and pyrazole scaffolds as acetylcholinesterase inhibitors","volume":"6","author":"Islam","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpet.2025.103606_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116311","article-title":"Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer\u2019s disease","volume":"45","author":"Bowroju","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127659","article-title":"Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation","volume":"30","author":"Du","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpet.2025.103606_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128212","article-title":"Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer\u2019s disease","volume":"49","author":"Nerella","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpet.2025.103606_bib97","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/molecules21040400","article-title":"Imidazopyranotacrines as non-hepatotoxic, selective acetylcholinesterase inhibitors, and antioxidant agents for Alzheimer\u2019s disease therapy","volume":"21","author":"Boulebd","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103606_bib98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bioorg.2018.08.009","article-title":"Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors","volume":"81","author":"Kumar","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib99","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1573409914666180604115425","article-title":"N-substituted aryl sulphonamides as potential anti-Alzheimer\u2019s agents: design, synthesis and biological evaluation","volume":"14","author":"Masand","year":"2018","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.jpet.2025.103606_bib100","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4155\/fmc-2019-0106","article-title":"Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer\u2019s disease","volume":"11","author":"Swetha","year":"2019","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104770","article-title":"Design, synthesis and evaluation of dihydropyranoindole derivatives as potential cholinesterase inhibitors against Alzheimer\u2019s disease","volume":"110","author":"Shaikh","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib102","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/adsc.201801471","article-title":"Recent trends in iron-catalyzed reactions towards the synthesis of nitrogen-containing heterocycles","volume":"361","author":"Sreedevi","year":"2019","journal-title":"Adv Synth Catal"},{"key":"10.1016\/j.jpet.2025.103606_bib103","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1039\/D0OB02600J","article-title":"Multicomponent reactions as a potent tool for the synthesis of benzodiazepines","volume":"19","author":"Farhid","year":"2021","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38236-0","article-title":"The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents","volume":"13","author":"Pourtaher","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103606_bib105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","article-title":"Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for Alzheimer\u2019s disease","volume":"168","author":"Chalupova","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib106","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/jm0503289","article-title":"Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer\u2019s disease","volume":"48","author":"Mu\u00f1oz-Ruiz","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib107","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4155\/fmc-2020-0184","article-title":"Design and synthesis of novel tacrine\u2013indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Hamulakova","year":"2021","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113783","article-title":"Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau","volume":"225","author":"Wichur","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib109","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1039\/D2RA05105B","article-title":"Synthesis, characterization, and in vitro anti-cholinesterase screening of novel indole amines","volume":"13","author":"Gondal","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.jpet.2025.103606_bib110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/acschemneuro.5b00082","article-title":"Curcumin\/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP\/PS1 mouse model","volume":"6","author":"Gerenu","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jpet.2025.103606_bib111","doi-asserted-by":"crossref","first-page":"11819","DOI":"10.1021\/acs.jmedchem.0c01021","article-title":"Characterization and discovery of a selective small-molecule modulator of mitochondrial complex I targeting a unique binding site","volume":"63","author":"Green","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128081","article-title":"Structural understanding of 5-(4-hydroxy-phenyl)-N-(2-(5-methoxy-1H-indol-3-yl)-ethyl)-3-oxopentanamide as a neuroprotectant for Alzheimer\u2019s disease","volume":"43","author":"Saathoff","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpet.2025.103606_bib113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/ph16030355","article-title":"Design, synthesis, and neuroprotective activity of phenoxyindole derivatives on antiamyloid beta (A\u03b2) aggregation, antiacetylcholinesterase, and antioxidant activities","volume":"16","author":"Laivut","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2025.103606_bib114","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1039\/C9CC01330J","article-title":"Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer\u2019s disease","volume":"55","author":"Meden","year":"2019","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.jpet.2025.103606_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114248","article-title":"From tryptophan-based amides to tertiary amines: optimization of a butyrylcholinesterase inhibitor series","volume":"234","author":"Meden","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2025.103606_bib116","doi-asserted-by":"crossref","first-page":"545","DOI":"10.17344\/acsi.2023.8460","article-title":"Synthesis and cholinesterase inhibitory activity of selected indole-based compounds","volume":"70","author":"Gro\u0161elj","year":"2023","journal-title":"Acta Chim Slov"},{"key":"10.1016\/j.jpet.2025.103606_bib117","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/biomedicines10071510","article-title":"Novel rivastigmine derivatives as promising multi-target compounds for potential treatment of Alzheimer\u2019s disease","volume":"10","author":"Vicente-Zurdo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpet.2025.103606_bib118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics16020281","article-title":"New multitarget rivastigmine\u2013indole hybrids as potential drug candidates for Alzheimer\u2019s disease","volume":"16","author":"Bon","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T10:12:28Z","timestamp":1753870348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":118,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022356525398198"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103606","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer\u2019s drug discovery: Promising futuristic structural designs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103606"}}